Listen now
Episode breakdown
Key takeaways
- Beyond regulatory approval, MedTech companies must demonstrate a device's value proposition across affordability, care quality, operational impact, and long-term value.
- Market selection is a critical commercialization factor, as reimbursement models and care delivery systems significantly differ between countries like the United States, the UK, Germany, and the Netherlands.
- A strong adoption case for medical devices requires evidence that extends beyond narrow technical performance data.
- Understanding economic logic across diverse healthcare markets is essential for successful MedTech product launches.
- The efficacy of a medical device in one regulatory environment does not guarantee commercial success or equivalent fit in others due to varying healthcare infrastructures.
A device can clear regulatory hurdles and still struggle commercially if the evidence is too narrow. MedTech companies need proof that speaks to affordability, care quality, operational impact, and long term value, not just technical performance.
Market selection matters just as much. The same solution may fit the United States, the UK, Germany, or the Netherlands very differently because reimbursement models, provider incentives, and care delivery systems are not built the same way.
Frequently asked questions
More episodes
Keep listening
-
Episode 76
Building Medical Devices Right the First Time with Helen Souris
With Helen Souris
-
Episode 75
What MedTech Can Learn from the Casino Industry with Melissa Aarskaug
With Melissa Aarskaug
-
Episode 74
The Future of Cardio-Oncology Wearables with Ryan Neely
With Ryan Neely
-
Episode 73
Navigating U.S. Market Entry for MedTech Developers with JJ Amell
With JJ Amell